Urinary Tract Infection Bacterial Clinical Trial
Official title:
Prospective Randomized, Double-blind, Parallel-controlled Versus Placebo in a Polyvalent Sublingual Bacterial Vaccine to 3 Months and 6 Months in Women With RUTI for the Immunomodulatory Efficacy Evaluation, Safety and Clinical Impact
The purpose of the study is to evaluate the efficacy and safety of a biological vaccine (MV140) in women with Recurrent Urinary Tract Infections (RUTI) compared with a placebo group.
Double blind parallel placebo controlled study. The subjects will receive medication during three or six months and will be followed up during another twelve months. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04291768 -
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
|
Phase 4 | |
| Recruiting |
NCT05667207 -
Dipsticks and Microscopy to Reduce Antibiotic Use in Women's Urinary Tract Infections: a Pilot Trial (MicUTI)
|
N/A | |
| Completed |
NCT04671290 -
Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae
|
||
| Completed |
NCT03774940 -
Blood Parameters as a Predictor of Fever After Percutaneous Nephrolithotomy
|
N/A | |
| Terminated |
NCT04287478 -
Bacteriophage Therapy in Patients With Urinary Tract Infections
|
Phase 1/Phase 2 | |
| Completed |
NCT03801213 -
Evaluation of Urine Samples Obtained by Bladder Stimulation for the Diagnosis of Urinary Tract Infection in Infants
|
N/A | |
| No longer available |
NCT04173013 -
Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)
|